INmune Bio Inc (INMB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $29.30M
Last updated: Nov 17, 2026 at 4:26 PM ET
INmune Bio Inc (INMB) Stock Chart
INmune Bio (INMB) has a latest price of $0.96 on Nov 17, 2026, 63.1% below its 52-week high of $2.60. Its price fell 32.4% over the past 12 months. The month-end price fell 92.1% over the 5 years through Oct 2026, a compound annual decline of 39.8%.
Price Chart
From Feb 2019 to Oct 2026, its highest month-end close was $23.72 in Aug 2021 and its lowest $1.13 in Mar 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart INMB with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for INMB.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 57.0%, and over 6 months it fell 31.9%. The month-end price fell 80.1% over the 3 years through Oct 2026, a compound annual decline of 41.6%.
| Period | Change |
|---|---|
| 1 month | -37.7% |
| 3 months | -57.0% |
| 6 months | -31.9% |
| 12 months | -32.4% |
| 12 months, with dividends | -32.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -80.1% | -41.6% |
| 5 years | -92.1% | -39.8% |
Price by Year
Its best calendar year was 2020, when the price rose 196.9%, and its weakest was 2025, when it fell 66.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.45 | -7.1% |
| 2025 | $1.56 | -66.6% |
| 2024 | $4.67 | -58.5% |
| 2023 | $11.26 | +77.6% |
| 2022 | $6.34 | -37.8% |
| 2021 | $10.20 | -40.8% |
| 2020 | $17.22 | +196.9% |
Trading Range
The price is 43.5% below its 50-day average of $1.70 and 40.2% below its 200-day average of $1.61.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.96 | |
| 52-week high | $2.60 | -63.1% |
| 52-week low | $0.89 | +7.5% |
| 50-day average | $1.70 | -43.5% |
| 200-day average | $1.61 | -40.2% |
Price Risk
Over 3 years, its largest fall from a peak was 93.2%.
| Measure | Value |
|---|---|
| 1-year beta | 2.57 |
| Largest fall, 1 year | -62.3% |
| Largest fall, 3 years | -93.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About INMB
What is INMB's 1-year price change?
INmune Bio's price fell 32.4% over the past 12 months. With dividends included, the 12-month total return was -32.4%.
What is INMB's 5-year price change?
INmune Bio's month-end price fell 92.1% over the 5 years through Oct 2026, a compound annual decline of 39.8%. These figures leave out dividends.
What is INMB's 52-week high and low?
INmune Bio's 52-week high is $2.60 and its 52-week low is $0.89. Its latest price of $0.96 on Nov 17, 2026 is 63.1% below the high.
What is INMB's beta?
INmune Bio's 1-year beta against the S&P 500 is 2.57, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 62.3%.
Is the INMB chart free?
Yes. Advanced Charting for INMB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
INMB pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors